News
3d
Live Science on MSNExperimental treatment for high cholesterol edits DNA in the body to reduce LDLAn experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific cholesterol-raising conditions.
A protein called PCSK9 determines how pancreatic cancer cells metastasize to different parts of the body. Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs ...
Lowering cholesterol can reduce a person’s overall risk of heart disease and heart attack. Learn about lifestyle strategies and drugs that may help.
The global PCSK9 Inhibitors market is expected to garner a market value of US$ 13 Billion Asia Pacific is expected to grow at a CAGR of 15% in the assessment period 2023-2033.
The drugs' effects go beyond LDL-lowering in ways that might potentially benefit hospitalized patients with COVID-19, at least those who are sickest, preliminary results suggest.
Newark, New Castle, USA, March 07, 2023 (GLOBE NEWSWIRE) -- As per the report published by Growth Plus Reports the Global PCSK9 inhibitor Market was estimated at US$ 1,476.7 million in 2021 and is ...
PHILADELPHIA, PA—For high-risk patients with heterozygous familial hypercholesterolemia (HeFH), a novel therapy that shuts off the PCSK9 gene can lower LDL cholesterol, early data from the heart-1 ...
Regulation of blood lipid levels is necessary for patients with cholelithiasis. Targeting PCSK9 and APOA4 may represent a promising approach for the prevention and treatment of cholelithiasis.
In a paper published in Science China Life Sciences, an Chinese research team present evidence to demonstrate that the upregulation of PCSK9 expression in endothelial cells of diabetic patients ...
How Does Repatha Work for High Cholesterol? People can have high cholesterol for a number of reasons, including their diet, exercise habits, or genetic conditions. Keeping your cholesterol low ...
PCSK9 and APOA4 were identified as key regulatory genes in the cholesterol metabolic pathway. PCSK9 knockdown increased APOA4 expression, while APOA4 overexpression led to reduced PCSK9 expression.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results